Cali Doctor CBD 1:1 Auto Feminised Seeds

Name: Cali Doctor CBD 1:1 Auto Feminised Seeds
SKU: MMG-CALIDR-CBD-AUTO-FEM
Rating: 5 (1 reviews)

SKU: MMG-CALIDR-CBD-AUTO-FEM Categories: Feminised Autoflowering, Grows Indoors & Outdoors, High CBD (5% +), High Yield, Indica, Low THC (- 10%), Medicinal Cannabis Seeds Tags: Arthritis, Cali Doctor CBD 1:1 Auto Feminised, Calming, Cancer, Chemotherapy Side-effects, Feminised Autoflowering, High CBD, High yield, Kush, Low THC, Medical Marijuana Genetics, Mostly Indica, Multiple Sclerosis, Pain, Pink Kush CBD x Afghani Auto, Relaxing, Soothing

We're Social - Spread the Love

Cali Doctor CBD 1:1 Auto Feminised Cannabis Seeds by Medical Marijuana Genetics

Cali Doctor CBD 1:1 Auto is an indica-dominant (605) and highly medicinal cannabis strain. A cross between Pink Kush CBD and Afghan Auto. Cali Doctor will produce pungent pink buds with strong aromas associated with Californian OG Kush. It is auto-flowering and takes as little as 9 weeks from germination through to harvest. In record time growers can be producing their own whole plant 1:1 medical cannabis oil from Cali Doctor CBD 1:1 Auto Feminised. Suitable for both indoor and outdoor grows, Indoor yields of 500g/m2 of grow space should be expected. Outdoors she will yield around 800g/plant.

A perfect medical strain to vape, providing the patient with a strong Kush flavour associated with high THC cannabis while offering an equal balance of CBD to counteract the psychoactive high.

This strain produces 8% of both CBD and THC and is recommended for treating arthritis, cancer, chemo-related side effects, chronic pain and multiple sclerosis.

Characteristics

Genetics: No selection
Pink Kush CBD x Afghani Auto

Variety: No selection
Mostly Indica

Flowering Time: No selection
63 – 70 days from seed

Flowering Type: No selection
Autoflowering

Sex: No selection
Feminised

THC Content: No selection
8%

CBD Content: No selection
High (5% +)

Yield: No selection
High

Grows: No selection
Grows Indoors, Grows outdoors

Medical Conditions: No selection
Arthritis, Cancer, Chemotherapy Side-effects, Multiple Sclerosis, Pain

Medical Properties: No selection
Yes

Effect: No selection
Calming, Relaxing, Soothing

Flavour: No selection
Kush

Genetics: No selection	Pink Kush CBD x Afghani Auto
Variety: No selection	Mostly Indica
Flowering Time: No selection	63 – 70 days from seed
Flowering Type: No selection	Autoflowering
Sex: No selection	Feminised
THC Content: No selection	8%
CBD Content: No selection	High (5% +)
Yield: No selection	High
Grows: No selection	Grows Indoors, Grows outdoors
Medical Conditions: No selection	Arthritis, Cancer, Chemotherapy Side-effects, Multiple Sclerosis, Pain
Medical Properties: No selection	Yes
Effect: No selection	Calming, Relaxing, Soothing
Flavour: No selection	Kush

Brand

Medical Marijuana Genetics

Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant in 2014. Whilst desperately treating the symptoms of one of the founders mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free. This enabled her to tend to her beloved garden, in the weeks leading up to her death. Medical Marijuana Genetics teamed with award winning breeders from Spain, with the initial aim of creating a line of CBD dominant cannabis strains. Using genetics from a number of well established strains, Medical Marijuana Genetics successfully created Candida (CD-1). Aptly named after the founder’s mother and meaning ‘bright light’ in Latin. Medical Marijuana Genetics have had results ranging from 20.65% CBD with 0.7% THC to 10.65% CBD to 0.39% THC. These percentages represent the highest known consistent ratios in a CBD-rich seed strain ever created in Europe. Medical Marijuana Genetics created a further 12 elite strains using Candida as a parent. They have selected their favourite's of these to release alongside their flagship Candida strain. These have been selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more. All of the strains that are being launched are CBD dominant and have a CBD content of over 8%, but some strains veer towards a 1:1 ratio. In 2017 MMG strains won 5 Spannabis Champions Cups in Barcelona and Madrid. The awards include a 1st (BCN), 2nd and 3rd place (MAD) in CBD categories for Orinoco OR1, Candida CD1 and Nightingale NN1 and a 2nd and 3rd in the Indica category for as yet unreleased genetics.